Adaptive Biotechnologies Corp (ADPT)
2.515
-0.08
(-3.27%)
USD |
NASDAQ |
Apr 25, 10:53
Adaptive Biotechnologies Total Assets (Quarterly): 661.13M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 661.13M |
| September 30, 2023 | 717.68M |
| June 30, 2023 | 764.54M |
| March 31, 2023 | 791.46M |
| December 31, 2022 | 856.62M |
| September 30, 2022 | 884.21M |
| June 30, 2022 | 806.63M |
| March 31, 2022 | 858.19M |
| December 31, 2021 | 923.34M |
| September 30, 2021 | 992.61M |
| June 30, 2021 | 1.033B |
| Date | Value |
|---|---|
| March 31, 2021 | 1.072B |
| December 31, 2020 | 1.116B |
| September 30, 2020 | 1.095B |
| June 30, 2020 | 854.82M |
| March 31, 2020 | 874.89M |
| December 31, 2019 | 912.30M |
| September 30, 2019 | 917.39M |
| June 30, 2019 | 601.40M |
| March 31, 2019 | 614.58M |
| December 31, 2018 | 332.69M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
601.40M
Minimum
Jun 2019
1.116B
Maximum
Dec 2020
880.77M
Average
874.89M
Median
Mar 2020
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 55.22M |
| Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 352.86M |
| Shareholders Equity (Quarterly) | 308.40M |
| Current Ratio | 4.660 |